View in EDS HTML Full Text PDF Full Text

Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway.

Saved in:
Bibliographic Details
Title: Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway.
Authors: Zeng H; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Province, Zhengzhou, 450046, China., Zeng X; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China., Wang C; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Province, Zhengzhou, 450046, China., Wang G; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China., Tian Q; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China., Zhao J; Department of Clinical Laboratory, Core Unit of National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450046, China., Zhao L; Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China., Li R; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China., Luo Y; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Province, Zhengzhou, 450046, China., Peng H; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China., Zhang Z; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China. ZQzhang111@outlook.com., Li X; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China. drlxf2080@163.com., Wu X; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China. wuxx-415@126.com.
Source: Drug delivery and translational research [Drug Deliv Transl Res] 2025 Mar; Vol. 15 (3), pp. 992-1010. Date of Electronic Publication: 2024 Jun 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38922561
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zeng+H%22">Zeng H</searchLink>; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Province, Zhengzhou, 450046, China.<br /><searchLink fieldCode="AU" term="%22Zeng+X%22">Zeng X</searchLink>; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.<br /><searchLink fieldCode="AU" term="%22Wang+C%22">Wang C</searchLink>; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Province, Zhengzhou, 450046, China.<br /><searchLink fieldCode="AU" term="%22Wang+G%22">Wang G</searchLink>; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.<br /><searchLink fieldCode="AU" term="%22Tian+Q%22">Tian Q</searchLink>; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.<br /><searchLink fieldCode="AU" term="%22Zhao+J%22">Zhao J</searchLink>; Department of Clinical Laboratory, Core Unit of National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450046, China.<br /><searchLink fieldCode="AU" term="%22Zhao+L%22">Zhao L</searchLink>; Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.<br /><searchLink fieldCode="AU" term="%22Li+R%22">Li R</searchLink>; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.<br /><searchLink fieldCode="AU" term="%22Luo+Y%22">Luo Y</searchLink>; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Province, Zhengzhou, 450046, China.<br /><searchLink fieldCode="AU" term="%22Peng+H%22">Peng H</searchLink>; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Z%22">Zhang Z</searchLink>; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China. ZQzhang111@outlook.com.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China. drlxf2080@163.com.<br /><searchLink fieldCode="AU" term="%22Wu+X%22">Wu X</searchLink>; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China. wuxx-415@126.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101540061%22">Drug delivery and translational research</searchLink> [Drug Deliv Transl Res] 2025 Mar; Vol. 15 (3), pp. 992-1010. <i>Date of Electronic Publication: </i>2024 Jun 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101540061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2190-3948 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222190393X%22">2190393X </searchLink><i>NLM ISO Abbreviation: </i>Drug Deliv Transl Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38922561
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13346-024-01653-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 992
    Titles:
      – TitleFull: Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zeng H
      – PersonEntity:
          Name:
            NameFull: Zeng X
      – PersonEntity:
          Name:
            NameFull: Wang C
      – PersonEntity:
          Name:
            NameFull: Wang G
      – PersonEntity:
          Name:
            NameFull: Tian Q
      – PersonEntity:
          Name:
            NameFull: Zhao J
      – PersonEntity:
          Name:
            NameFull: Zhao L
      – PersonEntity:
          Name:
            NameFull: Li R
      – PersonEntity:
          Name:
            NameFull: Luo Y
      – PersonEntity:
          Name:
            NameFull: Peng H
      – PersonEntity:
          Name:
            NameFull: Zhang Z
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Wu X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2190-3948
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Drug delivery and translational research
              Type: main
ResultId 1